Financials
- Market Capitalization 936.26 M
- Employee 1 976
- Founded 1996
- CEO N/A
- Website www.amphastar.com
- Headquarter California, United States
- FIGI BBG000BW90S6
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2318 | CRON Cronos Group Inc. - Common Share | 3.38 USD | -0.29% | +2.11% | +16.96% | +33.07% | 1.25 B USD | ||
| 2436 | PCRX Pacira BioSciences, Inc. - Common Stock | 25.76 USD | -0.27% | +4.72% | -4.10% | +18.00% | 1.03 B USD | ||
| 2592 | COLL Collegium Pharmaceutical, Inc. - Common Stock | 25.35 USD | -4.12% | -6.39% | -29.01% | -27.86% | 825.28 M USD | ||
| 2724 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.13 USD | -2.59% | -3.05% | +5.09% | +215.27% | 682.44 M USD |
Frequently asked questions about Amphastar Pharmaceuticals, Inc.
What is the Amphastar Pharmaceuticals, Inc. stock price today?
The current price of Amphastar Pharmaceuticals, Inc. (AMPH) is 22.01. Over the past 24 hours, the stock has changed by +0.59%. Follow the AMPH chart for real-time price dynamics.
What is the stock ticker of Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. trades under the ticker AMPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Amphastar Pharmaceuticals, Inc. stock going up?
AMPH has changed by +1.90% over the last week, +8.16% over the last month, and -9.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. currently has a market capitalization of 936.26 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Amphastar Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Amphastar Pharmaceuticals, Inc. reported earnings of 0.69 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Amphastar Pharmaceuticals, Inc. revenue for the last quarter?
Amphastar Pharmaceuticals, Inc. reported quarterly revenue of 183.9 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Amphastar Pharmaceuticals, Inc. net income for the last quarter?
Amphastar Pharmaceuticals, Inc. reported net income of 30.35 M for the last quarter. The previous quarter showed 6.42 M, which means net income changed by +372.71%.
How many employees does Amphastar Pharmaceuticals, Inc. have?
As of the latest available data, Amphastar Pharmaceuticals, Inc. has 1 976 employees. Workforce size can provide additional context about the company's scale and operations.
What is Amphastar Pharmaceuticals, Inc. EBITDA?
Amphastar Pharmaceuticals, Inc. EBITDA is 54.04 M, and its EBITDA margin is 29.39%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Amphastar Pharmaceuticals, Inc. stock?
You can buy Amphastar Pharmaceuticals, Inc. (AMPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Amphastar Pharmaceuticals, Inc. stock?
Investing in Amphastar Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AMPH chart and related analysis on metatrader.com as part of your research.